Robert McNamara - 15 Aug 2024 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Reporting relationship: Director
Issuer ticker: XTNT
Reported as of: 15 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Aug 2024, 16:49:21 UTC
Prior SEC filing: 06 Jun 2024
Next SEC filing: 20 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Amy E. Culbert, attorney-in-fact

Key filing fact

Robert McNamara filed Form 4 for Xtant Medical Holdings, Inc. (XTNT) on 19 Aug 2024.

Key facts

This page summarizes Robert McNamara's Form 4 filing for Xtant Medical Holdings, Inc. (XTNT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Aug 2024, 16:49.

Change

Previous filing in this sequence was filed on 06 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XTNT transaction

Common Stock

Award

Transaction value: $0
Shares: +162,162
Change %: +27%
Price: $0.000000
Shares after: 754,151
Date: 15 Aug 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2025, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date.

Footnote F2

Includes 307,342 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates.